Aim The objective of the study is to describe management of exomphalos major and investigate the effect of congenital cardiac anomalies. Methods A single-center retrospective review (with audit approval) was performed of neonates with exomphalos major (fascial defect ! 5cm AE liver herniation) between 2004 and 2014. Demographic and operative data were collected and outcomes compared between infants who had primary or staged closure. Data, median (range), were analyzed appropriately. Results A total of 22 patients were included, 20 with liver herniation and 1 with pentalogy of Cantrell. Gestational age was 38 (30-40) weeks, birth weight 2.7 (1.4-4.6) kg, and 13 (60%) were male. Two were managed conservatively due to severe comorbidities, 5 underwent primary closure, and 15 had application of Prolene (Ethicon Inc) mesh silo and serial reduction. Five died, including two managed conservatively, none primarily of the exomphalos. Survivors were followed up for 38 months (2-71). Cardiac anomalies were present in 20 (91%) patients: 8 had minor and 12 major anomalies. Twelve (55%) patients had other anomalies. Primary closure was associated with shorter length of stay (13 vs. 85 days, p ¼ 0.02), but infants had similar lengths of intensive care stay, duration of parenteral feeds, and time to full feeds. Infants with cardiac anomalies had shorter times to full closure (28 vs. 62 days, p ¼ 0.03), but other outcomes were similar. Conclusion Infants whose defect can be closed primarily have a shorter length of stay, but other outcomes are similar. Infants with more significant abdominovisceral disproportion are managed with staged closure; the presence of major cardiac anomalies does not affect surgical outcome.
Introduction
Exomphalos is an anterior abdominal wall defect affecting 1 in 5,000 neonates.
1 Up to 74% have other congenital anomalies, including heart defects, chromosomal anomalies (esp. trisomy 13 and 18), Beckwith-Wiedemann syndrome, and, rarely, midline syndromes (e.g., pentalogy of Cantrell, OEIS [omphalocele, exstrophy, imperforate anus, and spinal] syndrome, and lower midline syndrome).
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If the abdominal wall defect is ! 5 cm or if it contains the liver, it is defined as exomphalos major. It is an important clinical distinction, as surgical management differs from exomphalos minor, which can usually be closed primarily. In exomphalos major there is significant abdominovisceral disproportion that may make reduction of sac contents into the abdomen challenging or impossible. Traditionally management has been nonoperative, leaving the sac to epithelialize to enable later surgical closure. Current surgical options include primary closure (with/without a patch) and staged silo repair, which involves suturing a prosthetic silo to the defect edge, with or without sac excision. The silo is serially reduced over weeks, in theater or at the bedside. When the abdominal viscera are reduced, the silo is removed and the abdominal wall closed. Some authors advocate an aggressive surgical approach, 5 but this institution has published a series managed with staged repair between 1997 and 2004 6 who had good outcomes. We sought to update this series and investigate whether congenital heart disease affects the surgical and other outcomes. Moreover, though some patient characteristics clearly influence outcome, such as respiratory failure at birth that is a significant predictor of mortality, 7 it remains unclear whether infants with significant cardiac anomalies have worse outcomes.
Methods
A retrospective review of infants with exomphalos major (defined as an abdominal wall defect of ! 5 cm diameter with/without liver herniation) treated at Great Ormond Street Hospital was performed. Infants were included who presented from December 2004 to December 2014 inclusive (from the end of the previous study 6 ). Infants were excluded if they had primary treatment elsewhere. The study was approved as an audit. Demographic data and details of comorbidities were obtained from notes and information about cardiac anomalies from echocardiogram reports. Cardiac anomalies were considered major if the patient required cardiac surgery or longterm cardiology follow-up. The protocol for management was to offer primary closure if possible, and staged silo repair (as previously, leaving the sac intact 6 ) if abdominovisceral disproportion did not allow primary closure. Patients with severe comorbidities preventing surgical intervention were managed conservatively and excluded from further analysis. Details of operative closure were obtained and outcomes compared between infants who had primary closure and staged repair with a silo and between those with and without significant cardiac anomalies.
As exomphalos is associated with abnormal intestinal rotation, infants were investigated and offered Ladd's procedure if necessary. Laparoscopic Ladd's procedure is the institutional preference as it allows assessment of the rotational anomaly and the small bowel mesentery, with correction, if necessary, but reduced risk of adhesional bowel obstruction.
8-10
Data are presented as median (range) and compared with two-tailed Mann-Whitney U test, t-test, and Fisher's exact test as appropriate using GraphPad Prism v5 (GraphPad Software, Inc., San Diego, California, United States; 2007).
Results

Demographics and Patient Characteristics
A total of 22 patients presented with exomphalos major. Liver was herniated in 20 and 1 had pentalogy of Cantrell. Gestational age was 38 (30-40) weeks, birth weight 2.7 (1.4-4.6) kg, and 13 (60%) were male. Eighteen (82%) patients were delivered by cesarean section, 12 electively and 6 as an emergency.
Cardiac anomalies were present in 20 (91%) infants: 8 had minor and 12 had major anomalies. Some infants had more than one anomaly. Minor anomalies included small patent ductus arteriosus (PDA, 6), patent foramen ovale (PFO, 2), and small interatrial connection (2), none of which required surgical intervention or long-term follow-up. Major defects included PDA requiring intervention (7), atrial septal defect (ASD, 5), ventricular septal defect (VSD, 4), PFO requiring intervention (2), aortic arch abnormalities (3), double-outlet right ventricle (DORV, 2), coarctation (1), tetralogy of Fallot (1), dilated left ventricle (1), right ventricular hypoplasia (1), and mitral valve anomaly (1).
Twelve (55%) patients had other anomalies, including pulmonary hypoplasia with pulmonary hypertension (3), congenital diaphragmatic hernia (1 Bochdalek, 1 Morgagni), undescended testes (3), renal abnormalities (1 duplex kidney, 1 pelvic kidney), talipes equinovarus (1), and hypothyroidism (1). Two infants had a chromosomal anomaly: Xlinked ichthyosis (1) and Beckwith-Wiedemann syndrome (1). Eight infants had inguinal hernia (five bilateral and three unilateral).
Management
Two (9%) patients were managed conservatively due to overwhelming comorbidities-one had a left congenital diaphragmatic hernia (with no cardiac anomalies) and died on day 2 of life. The other had pulmonary hypoplasia and pulmonary hypertension, VSD, ASD, and PDA. The sac was painted with povidone iodine and saline and epithelialized. The patient died of respiratory distress syndrome precipitated by adenovirus infection 6 months later.
All other infants (20/22; 81%) were managed surgically. Five (23%) infants underwent primary closure at 2 days, [1] [2] [3] [4] [5] [6] [7] the defect was 6 (5-7) cm, and all had liver herniation. In four, full fascial closure was performed, and in one, only skin closure was possible. Four of these patients had major cardiac anomalies (►Fig. 1).
A staged approach was used in 15 (68%) infants: 7 with major cardiac anomalies (including one pentalogy of Cantrell) and 8 without, with silo application on day 1 (0-8). Infants had 6 (3-10) procedures to tuck the silo before definitive closure; 40% of tucks were at the bedside without anesthetic (30/75). Age at definitive closure was 37 (9-112) days, 13 (87%) achieved full fascial closure, and 2 were closed with a patch (Gore-Tex [Gore & Associates, Inc., Flagstaff, Arizona, United States] or Permacol [Medtronic, Minneapolis, United States]). One patch became infected, which required it to be removed. One infant required silo refashioning 2 days after formation. Nine days later the sac ruptured; tissue expanders were used to increase the abdominal domain but were replaced because of infection. Ultimately the abdominal wall was closed with a Strattice patch (LifeCell Corporation) and plastic surgical reconstruction. One infant had an ileal perforation (presumed necrotizing enterocolitis) while the silo was in place and underwent laparotomy with oversewing of the perforation at day 28. Another two had exploration of the bowel in the silo at days 5 and 9 due to suspected perforation. One infant had abdominal closure at day 20 but required silo refashioning at 30 days. The abdomen was subsequently closed at 70 days.
The position of the duodenojejunal flexure was assessed in all infants, either at primary repair (5) or by contrast study after abdominal wall closure (15) . Six (30%) infants had malrotation, and none were symptomatic. Five had laparoscopic Ladd's procedure at 5.5 (2.2-32) months, and one was assessed operatively: the mesentery was broad based, so Ladd's procedure was unnecessary.
Eleven (73%) patients in the staged closure group developed ventral hernia, compared with one (20%) in the primary repair group (p ¼ 1).
Primary Outcomes
Infants who survived were followed up for 38 (2-71) months and no infants were lost to follow-up. Five (23%) patients died at 7 (0-17) months, including the two managed conservatively (described previously), none primarily of the exomphalos. One infant in the primary closure group with coarctation of the aorta died at 27 days of sepsis and renal failure. Two who had delayed closure died from pulmonary hypertension with chronic lung disease (one in the cardiac anomaly group, one not). ►Fig. 1 shows outcome for all patients.
Primary closure infants had fewer episodes of sepsis As expected, infants in the primary closure group had a shorter time to full closure (2 [1] [2] [3] [4] [5] [6] [7] vs. 37 days, p < 0.05) and a shorter hospital stay (13 [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] vs. 85 days, p < 0.05), but other outcomes were not different (►Table 1, ►Fig. 2).
Effect of Cardiac Anomalies
To examine the effect of major cardiac anomalies on outcome, we grouped the 20 surgically managed patients into those with major cardiac anomalies (n ¼ 11) and those with either a minor anomaly or no cardiac defect (n ¼ 9 Staged closure patients with cardiac anomalies were closed earlier than those without at 28 (9-60) compared with 62 (17-112) days, p ¼ 0.03 (►Table 2, ►Fig. 2).
Patients with major cardiac anomalies had fewer procedures to achieve full closure (4 [1] [2] [3] [4] [5] [6] [7] [8] [9] There were no differences in ventilation duration, intensive care days, or time to full feeds between those with and without cardiac anomalies (►Table 2), whether or not they had staged closure. There was also no difference in mortality between the two groups (2/11 with cardiac anomalies vs. 1/9 without, p ¼ 1).
Discussion
Our results indicate that infants who underwent primary closure had a shorter time to closure and length of stay than those who had staged closure, as might be expected. However, there was no difference in duration of ventilation, intensive care stay, or time to full enteral feeds. Obviously the decision of whether to opt for primary versus staged closure depends on factors including size of defect and stability of the patient, and is made at the time of the first surgery. We had hypothesized that infants with major cardiac anomalies would have worse outcomes than those without, but found this was not the case. Furthermore, infants with major cardiac anomalies achieved abdominal wall closure earlier than those without. Major cardiac anomaly did not preclude primary closure, and it was not associated with increased mortality. This is a retrospective review, and the finding of shorter time to full closure may reflect a bias and is unlikely to be of clinical significance. We think that these data are important not because cardiac infants are closed more quickly, but because they do not require a longer time for closure.
Management of exomphalos major continues to present a problem, with no consensus on optimal treatment and each method having challenges. 11 The paucity of good-quality evidence is partly due to low incidence, with most publications documenting case reports or small case series. Outcomes have improved in recent years regardless of technique, presumably as neonatal intensive care has improved. The definitive goal is to achieve both skin and fascial coverage of abdominal contents. Current approaches include surgery in the neonatal period or later. Initial nonoperative management with sac epithelialization and application of topical agents is favored by many. [12] [13] [14] [15] [16] This may prevent respiratory complications and increased abdominal compartment pressure. However, it has disadvantages, including morbidity due to infection and wound complications, systemic absorption and toxicity of agents applied to the sac, and the requirement for later operative intervention.
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Many prefer neonatal repair. 18 Advocates of primary surgical closure highlight the benefits of reduced ventilation duration, shorter time to enteral feeds, and reduced hospital stay when compared with staged closure. 5 However, the defect size, degree of visceroabdominal disproportion, and presence of associated anomalies, as in this study, may preclude reduction in abdominal viscera and immediate closure.
A variety of methods of staged closure have been reported since Gross first described advancing skin flaps to cover the defect. 19 Staged silo reduction, as described in this and other large series, 5,6 is one such method, a modification of the technique described by Schuster. 20 Our practice is that patients with a silo remain in hospital. Closing with a silo allows earlier closure and aims for a fascial closure rather than a potentially more challenging procedure in childhood to close a large ventral hernia. Centers that opt for conservative management and later closure still usually keep the child in hospital until the sac has epithelialized, which may also result in a prolonged hospital stay. This study is the first to assess if significant cardiac anomalies affect outcome in staged management of exomphalos major and is one of the largest series reviewing neonatal primary and staged closure.
Our findings differ from those of a 2005 paper that demonstrated shorter duration of ventilation, intensive care stay, and time to enteral feeds in primary closure compared with staged closure.
5 The observed differences in gestation and weight between the two groups in that study, unlike ours, may explain this difference. Interestingly, in our study, earlier gestation did not preclude primary closure. Ours is a center for management of congenital cardiac anomalies, which may explain the higher incidence of significant cardiac anomalies (86%) than rates of 30 to 50% documented in the literature. 5, 21 This may also have contributed to the similar outcomes we observed in the primary and staged closure groups; with a lower threshold for staged closure rather than pursuing a more aggressive strategy of primary closure. Infants with concomitant congenital anomalies, including cardiac, provide additional challenges when considering management of exomphalos major. Complications of staged reduction, such as respiratory insufficiency, hemodynamic compromise, prosthesis infection, and inability to close the abdomen, lead many to adopt a more conservative approach. Furthermore, the severity of some anomalies may preclude neonatal operative intervention, as we found in two patients. Respiratory insufficiency at birth, in particular, has been shown to be an independent predictor of mortality in infants with giant exomphalos.
7 A study observed pulmonary hypertension in over one-third of patients, associated with increased duration of ventilation and length of stay, but no difference between staged and delayed closure. 22 Another large series described infants managed with the Gross technique, either neonatally or after conservative management, and found that major anomalies (including cardiac) had a greater effect on outcome than the surgical technique used, with a much higher mortality than found in our cohort (41% with major anomalies). This technique was, however, associated with lower incidence of ventral hernia than our staged silo technique.
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Staged reduction has been reported in several series including a study demonstrating comparable survival outcomes to series documenting delayed closure. 24 However, owing to the diverse nature of the anomalies, it is impossible to extrapolate any guidance as to which techniques should be applied to which populations. Interestingly this cohort of patients had more associated anomalies, including cardiac anomalies, than the previous series reported from our center, only 16% of whom had significant cardiac anomalies. 6 It is not clear whether this represents a change in referral patterns or obstetric practice, as studies of antenatally diagnosed exomphalos in recent years demonstrate a high termination rate. 25, 26 One limitation of this study is that it was retrospective in nature, and therefore some data, for instance accurate measurement of defect size, were inconsistently recorded. Our results demonstrate that patients with exomphalos major continue to present a challenge to pediatric surgeons and may have prolonged hospital stays if the defect cannot be closed primarily. Infants with significant cardiac anomalies can be managed with primary or staged closure, but do no worse than infants without major anomalies. These findings could be related to the early cardiologist involvement, but have the limitation related to any retrospective study. Prospective studies, such as the British Association of Pediatric 
